En español
NIDA

National Advisory Council Agenda

126th Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

May 2, 2017

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

9:00 a.m.

Call to Order
Nora Volkow, M.D. Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.,
Executive Secretary,
National Advisory Council on Drug Abuse,
Director, Division of Extramural Research, NIDA

9:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Therapeutics and Medical Consequences (DTMC)
Ivan Montoya, M.P.H., M.D, Acting Director

Division of Neuroscience and Behavior (DNB)
Roger Little, Ph.D., Acting Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Update on Tobacco Industry Funding Issue
Susan Weiss, Ph.D., Director, Division of Extramural Research

10:30 a.m. Break

WebEx Information (Open Session Only)

Topic: WebEx - 126th Meeting, National Advisory Council on Drug Abuse
Date and Time: Tuesday, May 2, 2017 - 10:30 a.m. Eastern Daylight Time, 7 hours
Meeting Number (Access Code):  291 034 912

Password: Success1

Add to Calendar

To start the online event

At least 30 minutes before the starting time:

  1. Start your meeting.
  2. If requested, enter in your name and email address.
  3. If a password is required, enter in the meeting password: Success1
  4. Click “Join”.

Join by phone

Call-in toll-free number (US/Canada) – 1-877-668-4493
Call-in toll number (US/Canada) – 1-650-479-3208
Meeting Access Code – 291 034 912

Open Session

10:45 a.m. Welcome and Opening Remarks
Nora Volkow, M.D. Director, NIDA
11:00 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
12:00 p.m. Council Discussion
Council Members
12:30 p.m. Lunch Break (Steering Group Meeting)
1:45 p.m.

Briefing on NASEM Marijuana Report: 

Background, Methods & Therapeutic Benefits
Sean Hennessy, Pharm.D., Ph.D.
Professor of Epidemiology in Biostatistics and Epidemiology
University of Pennsylvania

Adverse Effects & Recommendations
Sachin Patel, M.D., Ph.D.
James G. Blakemore Chair and Associate Professor of Psychiatry & Behavioral Sciences;
Associate Professor of Molecular Physiology & Biophysics and Pharmacology
Vanderbilt University

2:45 p.m.

Break

3:00 p.m.

The Biomedical Research Workforce: Supporting More Investigators Sustainability and Efficiently
Michael Lauer, M.D.
Deputy
Director,
Extramural Research, NIH

and
Jon Lorsch, Ph.D.
Director, NIGMS

4:00 p.m. Concept Clearances​
NIDA Staff
4:30 p.m. Public Comments
4:45 p.m. Adjourn

This page was last updated May 2017